100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
Salt Composition in both
Our Recommendation
Ketorotide 10mg DT Tablet 15s
2,160+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Pain relief
Customers also bought
More About Myketro 10mg Tablet DT
Benefits
In Pain relief Myketro 10mg Tablet DT belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. To obtain the maximum benefit, follow the prescribed instructions precisely. Do not take more or for longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Dissolve it in a glass of water before taking it. Myketro 10mg Tablet DT is to be taken with food.
How it works
Myketro 10mg Tablet DT is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).
Unsafe: Avoid consuming alcohol with Myketro 10mg Tablet DT as it is deemed unsafe.
Seek medical advice from your doctor: Myketro 10mg Tablet DT may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Caution Advised: Myketro 10mg Tablet DT should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Not Safe: Myketro 10mg Tablet DT may cause side effects which could affect your ability to drive. Myketro 10mg Tablet DT may make you feel dizzy, tired or drowsy, you may also get headaches, visual disturbances, vertigo or have difficulty sleeping. This may affect your driving ability.
Caution Advised: Myketro 10mg Tablet DT should be used with caution in patients with kidney disease. Dose adjustment of Myketro 10mg Tablet DT may be needed. Doctor consultation is advised. Use of Myketro 10mg Tablet DT is not recommended in patients with severe kidney disease.
Caution Advised: Myketro 10mg Tablet DT should be used with caution in patients with liver disease. Dose adjustment of Myketro 10mg Tablet DT may be needed. Doctor consultation is advised. Use of Myketro 10mg Tablet DT is not recommended in patients with severe liver disease and active liver disease. Inform your doctor if you develop any signs or symptoms of jaundice while taking this medicine.
What if I forget to take it?
If a dose of Myketro 10mg Tablet DT is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
bibevewadi, pune-411014, maharashtra, india
References
Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 628
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 986
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 760-62
Ketorolac. Nutley, New Jersey: Roche Laboratories Inc.; 2013 (02 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (02 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
